US Authorizes AstraZeneca Covid Treatment In Some Cases
Faizan Hashmi Published December 09, 2021 | 08:50 AM
Washington, Dec 9 (UrduPoint / Pakistan Point News - 9th Dec, 2021 ) :US health authorities on Wednesday authorized the use of synthetic antibodies developed by AstraZeneca to prevent Covid-19 infections in people who react badly to vaccines.
It was the first time the food and Drug Administration has given emergency authorization for such a purely preventative treatment.
The FDA warned the drug Evusheld is "not a substitute for vaccination in individuals for whom Covid-19 vaccination is recommended" and can only be authorized for people who have a weakened immune system or those who cannot be vaccinated for medical reasons, such a strong allergic reaction.
In those cases, the drug can be administered to people aged 12 and up.
Evusheld combines two types of synthetic antibodies (tixagevimab and cilgavimab), and is given as two intramuscular injections, one straight after the other. These antibodies help the immune system fight off the virus by targeting its spike protein, which allows it to enter cells and infect them.
The FDA said that the treatment "may be effective for pre-exposure prevention for six months.
" It cannot be administered to someone who is already infected with the virus, the FDA said, although AstraZeneca is testing it for such treatment.
Side effects may include an allergic reaction, bleeding from the injection site, headache, and fatigue.
The FDA authorization was based on a clinical trial carried out on unvaccinated people over 59 years of age, or with a chronic disease, or at high risk of infection.
The drug was given to 3,500 people while 1,700 received a placebo. The trial showed that the treatment cut the risk of developing Covid-19 by 77 percent.
Two cocktails of antibodies, made by Regeneron and Eli Lilly, are currently authorized for prevention of infection in the United States, but only in people who have been exposed to the virus shortly before, or who have a strong chance of being exposed, such as employees of retirement homes or prisons.
In addition to being immunocompromised or unvaccinated, these people must also be at high risk of developing a severe case of the disease.
Related Topics
Recent Stories
Mired in crisis, Boeing reports another loss
Session Awarding Ceremony 2024 held at Cadet College Muzaffarabad
Austrian ski great Hirscher to make comeback under Dutch flag
Pakistan, Japan agrees to convene 'Economic Policy Dialogue'
FM Dar conveys deepest sympathy on torrential rains devastation in UAE
Spain PM Sanchez says weighing resignation after wife's graft probe
Tennis: ATP/WTA Madrid Open results - 1st update
Long-lost Klimt portrait auctioned off for 30 mn euros
Osaka seals first win on clay since 2022 in Madrid
Earthquake jolts Karachi
Sindh minister orders operation after attack on police in Ghotki
TikTok to fight US ban law in courts
More Stories From Miscellaneous
-
PDMA predicts gusty wind, rain with thunder, hails
1 day ago -
Iranian president Raisi given guard of honour at PM House
3 days ago -
Intellectuals, writers accolades Naseer Mirza on his literary contribution
3 days ago -
Bahawalpur Adabi Sangat hosts memorable mushaira
4 days ago -
Cattle farming vital to alleviate poverty in rural areas
4 days ago -
Pakistan: A land of tourism, archeological wonders
4 days ago
-
Transforming education sector: from job hunters to job creators
6 days ago -
Amjad Bobby remembered on 19th death anniversary for timeless contributions to music
10 days ago -
Legendary actor Nadeem’s 26 films released on Eid-ul-Fitr days in 50 years
11 days ago -
Besant Hall Cultural Centre to celebrate evening with Sanam Marvi on 26 April
11 days ago -
Radio Bahawalpur presents program “Eidi Shidi”
14 days ago -
Radio Bahawalpur to broadcast Eid programs
16 days ago